Adalimumab (ADD-ah-lim-u-mab) is used
to decreased signs, symptoms, and progression of moderately to severely active
rheumatoid arthritis. It is intended for use in patients who have not responded
well to other Disease Modifying Antirheumatic Drugs (DMARDS). Adalimumab can
be used in combination with methotrexate or other DMARD's.
This medicine is available only with your doctor's prescription, in the
following dosage forms:
Some commonly used brand names are:
In the U.S. -
Generic name product may be available in the U.S.
† Not commercially available in Canada.